PUBLISHER: Acute Market Reports | PRODUCT CODE: 1561001
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1561001
Neurovascular Embolization Devices Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The neurovascular embolization devices market is primarily focused on specialized medical equipment used in endovascular surgeries to treat neurovascular diseases like aneurysms and arteriovenous malformations. These devices play a pivotal role in blocking blood flow to a particular area of the brain, helping reduce the risk of rupture and subsequent strokes. With an aging global population and increasing rates of neurovascular diseases, the demand for these advanced medical devices has surged. The neurovascular embolization devices market is estimated to grow at a CAGR of 6.4% from 2024 to 2032.
Driving Force: Rise in Neurovascular Diseases
A prominent force steering the growth of the neurovascular embolization devices market is the alarming rise in neurovascular diseases globally. According to the World Health Organization, cerebrovascular diseases, which encompass conditions like strokes and aneurysms, account for 6.5 million deaths each year, making them the second leading cause of death and the third leading cause of disability. With the world witnessing an uptick in lifestyle-related diseases such as hypertension and diabetes, the incidence of neurovascular disorders has escalated. Besides, the geriatric population, naturally more susceptible to such conditions, is growing steadily. As per the United Nations, by 2050, one in six people in the world will be over age 65, up from one in 11 in 2019. This demographic shift, coupled with the increasing incidence of neurovascular diseases, underscores the dire need for effective neurovascular embolization devices.
Opportunity: Technological Advancements in Neurosurgery
Technological innovations present a lucrative opportunity in this market. As surgeries become more complex, there's a burgeoning demand for devices that offer greater precision, reduced invasiveness, and better patient outcomes. For instance, advancements in materials used for devices have enabled the creation of flexible, biocompatible coils and stents that can be more easily navigated through the intricate neurovascular system. Additionally, the integration of AI and real-time imaging has allowed for better visualization and more precise placement of these devices. Hospitals and healthcare institutions are increasingly recognizing these benefits, and there's a notable trend of them investing in cutting-edge neurosurgical equipment to bolster patient care and improve surgical success rates.
Restraint: High Costs and Limited Accessibility in Developing Regions
However, the neurovascular embolization devices market isn't without its constraints. A primary restraint is the high cost associated with these devices, and the subsequent surgeries. These advanced devices, often utilizing state-of-the-art materials and technologies, come with a hefty price tag. Furthermore, the surgeries involving these devices require specialized training and equipment, adding to the overall costs. Such expenses make these treatments inaccessible to a vast majority in low and middle-income countries. Even in developed nations, the high costs can deter individuals without comprehensive health insurance from opting for these treatments, thus limiting the market's growth potential.
Challenge: Need for Specialized Training and Risk of Complications
A significant challenge facing this market is the requisite specialized training for healthcare professionals. Utilizing neurovascular embolization devices is intricate and demands a high skill level. A slight misstep can lead to severe complications such as hemorrhage, thrombosis, or even death. While many leading medical institutions and manufacturers offer training programs, the steep learning curve remains a concern. Furthermore, post-surgical complications like coil migration or stent displacement pose risks. Although rare, when such complications arise, they can be life-threatening and significantly impact a patient's quality of life.
Market Segmentation by Product
As of 2023, Embolic Coils held a dominant share in terms of revenue. Primarily used in endovascular coiling, these devices are preferred for their minimally invasive nature, thereby reducing recovery times and hospital stays. Flow Diversion Devices, with their unique design to divert blood flow away from an aneurysm, followed closely in revenue generation. They have gained popularity due to their efficacy in treating large or giant neck aneurysms, which are often challenging to manage with traditional methods. However, Liquid Embolic Agents are anticipated to witness the highest CAGR from 2024 to 2032. These agents, when introduced into the bloodstream, solidify and block abnormal blood vessels, and their increasing applicability in a range of neurovascular conditions is driving their market demand. Aneurysm Clips, although essential in treating ruptured aneurysms, have seen a slower growth due to the surge in preference for less invasive treatments.
Market Segmentation by End-Use
Delineating the market based on end-use, Hospitals, given their infrastructure and accessibility, constituted the highest revenue share in 2023. They are often the primary choice for critical procedures due to the availability of specialized equipment and skilled professionals. Specialty Clinics, focusing on targeted treatments, are predicted to register the highest CAGR in the decade leading to 2032. Their rise can be attributed to the personalized care they offer and the rapid adoption of advanced technologies. Other facilities, including outpatient centers, held a minor market share but remain essential, especially in regions where hospital infrastructure might be sparse.
Market Segmentation by Region
From a geographical standpoint, North America, in 2023, dominated the market revenue for neurovascular embolization devices. Factors such as advanced healthcare facilities, increased awareness, and higher expenditure on healthcare played a pivotal role. However, the Asia-Pacific region is expected to outpace others in CAGR from 2024 to 2032. This expected surge is due to the amalgamation of an aging population, increasing healthcare infrastructure, and rising awareness about neurovascular diseases in countries like China and India. Europe, with its robust healthcare system, will continue to be a significant player, whereas Latin America and the Middle East & Africa, though holding smaller shares, present potential growth avenues, especially with increasing investments in healthcare.
Competitive Trends
In terms of competitive trends, the neurovascular embolization devices market, in 2023, saw a few major players steering its trajectory. Companies like Medtronic, Stryker, MicroVention Inc, Cerenovus, Integra LifeSciences, Penumbra Inc, Balt SAS, B. Braun Melsungen AG, and Phenox GmbH had set deep roots with their innovative product lines and expansive distribution networks. Their strategies often entailed research and development spurts, aiming at product innovation, and collaborations or acquisitions to expand their global footprint. As we peer into the horizon from 2024 to 2032, it's expected that these conglomerates will delve deeper into technological integration, possibly harnessing AI and real-time data analytics, to make devices more efficient and patient-friendly. Emerging players, on the other hand, will try to carve niches by addressing specific market gaps or by introducing cost-effective solutions for developing regions.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Neurovascular Embolization Devices market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Neurovascular Embolization Devices market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Product
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Aneurysm Clips
End-Use
- Hospitals
- Specialty Clinics
- Others
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Neurovascular Embolization Devices market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Neurovascular Embolization Devices market?
Which is the largest regional market for Neurovascular Embolization Devices market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Neurovascular Embolization Devices market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Neurovascular Embolization Devices market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Neurovascular Embolization Devices Market
- 2.2. Global Neurovascular Embolization Devices Market, By Product, 2023 (US$ Million)
- 2.3. Global Neurovascular Embolization Devices Market, By End-Use, 2023 (US$ Million)
- 2.4. Global Neurovascular Embolization Devices Market, By Geography, 2023 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2023
3. Neurovascular Embolization Devices Market: Competitive Analysis
- 3.1. Market Positioning of Key Neurovascular Embolization Devices Market Vendors
- 3.2. Strategies Adopted by Neurovascular Embolization Devices Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Neurovascular Embolization Devices Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Neurovascular Embolization Devices Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Embolic Coils
- 5.3.2. Flow Diversion Devices
- 5.3.3. Liquid Embolic Agents
- 5.3.4. Aneurysm Clips
6. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Hospitals
- 6.3.2. Specialty Clinics
- 6.3.3. Others
7. North America Neurovascular Embolization Devices Market, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 7.3. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 7.4.Neurovascular Embolization Devices Market: By Region, 2022-2032, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 7.4.1.1.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 7.4.1.2.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 7.4.1.3.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Neurovascular Embolization Devices Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.3. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.Neurovascular Embolization Devices Market: By Region, 2022-2032, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.4.1.1.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.4.1.2.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.4.1.3.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.4.1.4.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.4.1.5.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 8.4.1.6.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Neurovascular Embolization Devices Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.3. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.Neurovascular Embolization Devices Market: By Region, 2022-2032, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.4.1.1.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.4.1.2.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.4.1.3.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.4.1.4.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.4.1.5.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 9.4.1.6.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Neurovascular Embolization Devices Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 10.3. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 10.4.Neurovascular Embolization Devices Market: By Region, 2022-2032, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 10.4.1.1.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 10.4.1.2.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 10.4.1.3.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Neurovascular Embolization Devices Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 11.3. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 11.4.Neurovascular Embolization Devices Market: By Region, 2022-2032, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 11.4.1.1.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 11.4.1.2.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Neurovascular Embolization Devices Market: By Product, 2022-2032, USD (Million)
- 11.4.1.3.2. Neurovascular Embolization Devices Market: By End-Use, 2022-2032, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. Medtronic
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. Stryker
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. MicroVention Inc
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. Cerenovus
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Integra LifeSciences
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. Penumbra Inc
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. Balt SAS
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. B. Braun Melsungen AG
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
- 12.9. Phenox GmbH
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
- 12.10. Other Notable Players
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 2 Global Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 3 North America Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 4 North America Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 5 U.S. Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 6 U.S. Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 7 Canada Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 8 Canada Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 9 Rest of North America Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 10 Rest of North America Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 11 UK and European Union Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 12 UK and European Union Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 13 UK Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 14 UK Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 15 Germany Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 16 Germany Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 17 Spain Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 18 Spain Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 19 Italy Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 20 Italy Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 21 France Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 22 France Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 23 Rest of Europe Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 24 Rest of Europe Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 25 Asia Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 26 Asia Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 27 China Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 28 China Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 29 Japan Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 30 Japan Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 31 India Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 32 India Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 33 Australia Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 34 Australia Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 35 South Korea Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 36 South Korea Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 37 Latin America Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 38 Latin America Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 39 Brazil Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 40 Brazil Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 41 Mexico Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 42 Mexico Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 43 Rest of Latin America Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 44 Rest of Latin America Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 45 Middle East and Africa Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 46 Middle East and Africa Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 47 GCC Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 48 GCC Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 49 Africa Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 50 Africa Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
- TABLE 51 Rest of Middle East and Africa Neurovascular Embolization Devices Market By Product, 2022-2032, USD (Million)
- TABLE 52 Rest of Middle East and Africa Neurovascular Embolization Devices Market By End-Use, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Neurovascular Embolization Devices Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Neurovascular Embolization Devices Market: Quality Assurance
- FIG. 5 Global Neurovascular Embolization Devices Market, By Product, 2023
- FIG. 6 Global Neurovascular Embolization Devices Market, By End-Use, 2023
- FIG. 7 Global Neurovascular Embolization Devices Market, By Geography, 2023
- FIG. 8 Market Geographical Opportunity Matrix - Global Neurovascular Embolization Devices Market, 2023
FIG. 9Market Positioning of Key Neurovascular Embolization Devices Market Players, 2023
FIG. 10Global Neurovascular Embolization Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 11 Global Neurovascular Embolization Devices Market, By Product, 2023 Vs 2032, %
- FIG. 12 Global Neurovascular Embolization Devices Market, By End-Use, 2023 Vs 2032, %
- FIG. 13 U.S. Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 14 Canada Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 15 Rest of North America Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 16 UK Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 17 Germany Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 18 Spain Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 19 Italy Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 20 France Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 21 Rest of Europe Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 22 China Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 23 Japan Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 24 India Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 25 Australia Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 26 South Korea Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 27 Rest of Asia Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 28 Brazil Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 29 Mexico Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 30 Rest of Latin America Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 31 GCC Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 32 Africa Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
- FIG. 33 Rest of Middle East and Africa Neurovascular Embolization Devices Market (US$ Million), 2022 - 2032
